Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies

Numerous antiangiogenic agents are approved for the treatment of oncological diseases. However, almost all patients develop evasive resistance mechanisms against antiangiogenic therapies. Currently no predictive biomarker for therapy resistance or response has been established. Therefore, the aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pircher, Andreas, Jöhrer, Karin, Kocher, Florian, Steiner, Normann, Graziadei, Ivo, Heidegger, Isabel, Pichler, Renate, Leonhartsberger, Nicolai, Kremser, Christian, Kern, Johann, Untergasser, Gerold, Gunsilius, Eberhard, Hilbe, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991441/
https://www.ncbi.nlm.nih.gov/pubmed/26956051
http://dx.doi.org/10.18632/oncotarget.7915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991441/
https://www.ncbi.nlm.nih.gov/pubmed/26956051
http://dx.doi.org/10.18632/oncotarget.7915

Ejemplares similares